학술논문
Necessity of continuous tolvaptan administration based on the results of a placebo-control trial: A post-hoc analysis based on the pivotal Phase 3 trial / 治験時のデータからみたTolvaptan投与継続の必要性：第3相試験に基づくPost hoc analysis
Document Type
Journal Article
Author
Source
肝臓 / Kanzo. 2018, 59(11):633
Subject
Language
Japanese
ISSN
0451-4203
1881-3593
1881-3593
Abstract
Results: Of the 38 patients, 33 (86.8%) belonged to the rebound group and 5 (13.2%) to the non-Rebound group. Ascites volume at Day-0 and Day-7 was extracted as an independent factor.